News

Intra-Cellular Therapies Set for Financial Results Call

Intra-Cellular Therapies Set for Financial Results Call

Intra-Cellular Therapies Plans Financial Results Discussion

Intra-Cellular Therapies, Inc. (NASDAQ: ITCI), a leading biopharmaceutical company dedicated to developing treatments for central nervous system (CNS) disorders, has announced an upcoming conference call and live webcast slated for the morning of October 30, 2024. The call is scheduled to commence at 8:30 a.m. Eastern Time, where company executives will provide substantial updates and discuss the financial performance for the quarter that ended on September 30, 2024.

Details of the Upcoming Conference

Participants interested in attending the call via phone must complete an online registration process using the provided link ahead of the event. This will ensure a seamless experience as Intra-Cellular Therapies prepares to share critical insights and performance metrics. Attendees are advised to log in approximately 5 to 10 minutes before the scheduled start to register and download any necessary software for the webcast.

How to Join the Call

By following the registration link, potential attendees will complete the necessary steps to secure their participation in this important discussion. The conference call will not only delve into financial results but also offer a broader perspective on the company’s strategic directions and innovations in the treatment of psychiatric and neurologic diseases.

About Intra-Cellular Therapies

Intra-Cellular Therapies is groundbreaking in its approach, stemming from Nobel Prize-winning research that aims to unlock new therapeutic pathways within human cells. This biopharmaceuticals firm focuses on the potential complexities of CNS disorders and is committed to advancing treatment options that can significantly enhance the quality of life for patients. With a commitment to innovation, the company is paving the way for revolutionary therapies aimed at some of the most challenging healthcare issues.

Commitment to Innovation and Research

The innovative mindset of Intra-Cellular Therapies stems from its dedication to understanding how internal cellular processes can be utilized to combat various disorders. This scientific approach is what sets the company apart in the biopharmaceutical arena, enabling it to explore new therapeutic options that could lead to improved outcomes in CNS treatment and management.

Company Contact Information

For those interested in further information or press inquiries, Intra-Cellular Therapies encourages reaching out to their Vice President, Corporate Communications, and Investor Relations, Dr. Juan Sanchez. Dr. Sanchez can provide additional insights and is reachable at 646-440-9333. Alternatively, for media inquiries, Cameron Radinovic from Burns McClellan, Inc. is available at 646-930-4406 or through email.

Frequently Asked Questions

What is the purpose of the conference call?

The conference call is intended to provide a corporate update and discuss financial results for Intra-Cellular Therapies.

When is the conference call scheduled?

The call is set for October 30, 2024, at 8:30 a.m. Eastern Time.

How can I access the webcast?

Participants can access the webcast through the Investors section on Intra-Cellular Therapies’ website.

Who should I contact for more information about the event?

For detailed inquiries regarding the event, you can contact Dr. Juan Sanchez or Cameron Radinovic for assistance.

What is the focus of Intra-Cellular Therapies?

The company focuses on the development of therapeutics for central nervous system disorders through an innovative cellular approach.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Class Action Alerts: M&A Under Scrutiny

Updated Category News Views 24

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Continue Reading
Power Knot MEA Wins THE BIZZ 2026 for Excellence

Updated Category News Views 22

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Continue Reading
Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Updated Category News Views 20

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Continue Reading
Black Culture Icon: Plastic-Covered Couch Takes Stage

Updated Category News Views 26

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Continue Reading
Monteverde Probes Four Key M&A Deals for Fairness

Updated Category News Views 37

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

Continue Reading
Lawsuit Highlights Inaction in School Bus Tragedy

Updated Category News Views 20

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

Continue Reading
Blokees Unveils 90+ New Wonders at Shanghai Fest

Updated Category News Views 16

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Continue Reading
SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Updated Category News Views 16

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Continue Reading
ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

Updated Category News Views 24

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Continue Reading
Monster Energy Dominates Skateboard Podium at SLS Paris

Updated Category News Views 19

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Continue Reading

Top 5 Most Recently Viewed Articles

Recurrent Energy Gains $415 Million to Propel Global Growth

Updated Category News Views 131

Recurrent Energy Secures Major Financing for Expansion Recurrent Energy, a subsidiary of Canadian Solar Inc. (NASDAQ: CSIQ), has successfully secured a substantial multi-currency credit facility valued at up to $415 million. This critical investment is set to bolster the company's financial foundation as it seeks to scale its global renewable energy portfolio and take on...

Continue Reading
Ultragenyx Pharmaceutical Expands Team with Stock Grants

Updated Category News Views 166

Ultragenyx Pharmaceutical Initiates New Stock Grant Program Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a leading biopharmaceutical company, has recently taken significant steps to strengthen its workforce by granting restricted stock units to newly hired non-executive officers. This decision was announced as part of the company’s ongoing commitment to the...

Continue Reading
Worm Power Receives Major USDA Grant to Boost Production

Updated Category News Views 370

Worm Power Secures Substantial Funding to Enhance Production A New York-based company, Worm Power, is taking significant steps to expand its operations and improve production methods in response to the increasing demand for their sustainable fertilizer products. Recently, they announced the acquisition of a sizable $900,000 grant from the U.S. Department of Agriculture...

Continue Reading
Leidos Holdings Renews Commitment with Quarterly Cash Dividend

Updated Category News Views 158

Leidos Holdings Declares Quarterly Cash Dividend Leidos Holdings, Inc. (NYSE: LDOS) has made a significant announcement regarding its financial strategy. The company's board of directors has officially declared a quarterly cash dividend of $0.40 for every outstanding share of its common stock. This dividend showcases Leidos' commitment to providing value to its...

Continue Reading
Kura Sushi Prepares to Release Q3 Earnings Amid Analyst Changes

Updated Category News Views 207

Kura Sushi Audiences Await Q3 Earnings Report Kura Sushi USA, Inc. (NASDAQ: KRUS) is gearing up to present its third quarter earnings, with analysts eagerly predicting the company's financial performance. The anticipated earnings report is set to be unveiled before the opening bell. Analyst Expectations for Q3 Performance Foremost analysts are forecasting a slight...

Continue Reading